ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z
  • Abstract Number: 2548
    M-CSF-R Is a Critical Determinant for the Differentiation of Classical to Non-Classical Monocytes
  • Abstract Number: 1908
    Macitentan Responsiveness Supports the Validity of a Murine Model of Pulmonary Hypertension in Scleroderma Associated with Altered Tgfbeta/BMPR2 Signalling
  • Abstract Number: 1456
    Macrophage Activation Syndrome and Familial Hemophagocytic Lymphohistiocytosis: Is Their Clinical Phenotype Really Similar?
  • Abstract Number: 2424
    Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis Patients Treated with Canakinumab: Results from Phase 3 Trial Program
  • Abstract Number: 3217
    Macrophage Depletion Using a Specific CSF-1R Kinase Inhibitor Ameliorates Kidney and Skin Disease in a Mouse Model of Systemic Lupus Erythematosus
  • Abstract Number: 2208
    Macrophage Migration Inhibitory Factor: A Novel Biomarker in Ankylosing Spondylitis That Can Drive Spinal Fusion
  • Abstract Number: 424
    Magnetic Resonance and Echocardiographic Strain Rate Imaging for the Early Detection of  Cardiac Involvement in Juvenile Systemic Sclerosis
  • Abstract Number: 313
    Magnetic Resonance Imaging Outcomes Using an Intra-Articular Injection (SM04690) in the Treatment of Osteoarthritis of the Knee: Interim, Exploratory Analysis of Results from a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study
  • Abstract Number: 2356
    Major Cardiovascular Events in Gout Patients with Cardiovascular Disease or Heart Failure and Chronic Kidney Disease Initiating on Allopurinol or Febuxostat (Uloric)
  • Abstract Number: 2671
    Male Gender and Higher Hemoglobin Predict Response to Methotrexate in Rheumatoid Arthritis
  • Abstract Number: 1684
    Malignancies in Patients with Incident Psoriatic Arthritis 1970-2008 in Relation to a Comparator Cohort: A Population-Based Case-Control Study
  • Abstract Number: 571
    Malignancy Data in Tofacitinib-Treated Japanese Patients with Rheumatoid Arthritis
  • Abstract Number: 1386
    Malignancy Prevalence Is Increased Among Patients before the Onset of IgG4-Related Disease
  • Abstract Number: 399
    Management of Lupus Anticoagulant Hypoprothrombinemia Syndrome in Juvenile Systemic Lupus Erythematosus – Single Center Experience
  • Abstract Number: 1044
    Many Patients with Early Rheumatoid Arthritis Want Triple Therapy: An Analysis Combining Comparative Effectiveness Research and Patients Preferences to Inform Treatment Recommendations
  • Abstract Number: 779
    Mapping Perceptions of Medication Decision Making Facilitators: The Importance of Patient Context
  • Abstract Number: 3143
    Mapping the Back-Door Routes into the Vascular Wall: 3D Microscopic Reconstruction of Microvasculature in the Normal Temporal Artery and in Giant Cell Arteritis
  • Abstract Number: 1441
    Marine Oil Supplements for Arthritis Pain: A Systematic Review and Meta-Analysis of Randomized Trials
  • Abstract Number: 1285
    Markers of Non-Compliance with ASAS/EULAR Management Recommendations Among Early Spa Patients: Evidence over 3 Years in the DESIR Cohort
  • Abstract Number: 663
    Mases Correlates Linearly with Disease Activity and Patient Related Outcomes in Patients with Axial Spondyloarthritis within the Scqm Cohort
  • Abstract Number: 360
    Massive Elimination of Multinucleated Osteoclasts By Eupatilin Is Due to Dual Inhibition of Transcription and Cytoskeletal Rearrangement
  • Abstract Number: 200
    Mast Cell Regulation of Aortic IL-6 Expression Involves Histamine-1 Receptor, Suppressor of Cyotkine Signaling-1 and IL-10
  • Abstract Number: 2999
    Maternal Microchimerism Is Increased in Multiple Cellular Subsets of Patients with Systemic Sclerosis Compared to Healthy Controls
  • Abstract Number: 1101
    Matrix Metalloproteinase-10 (Stromelysin 2) Is a Target of Robust Autoimmune T and B Cell Responses in Antibiotic-Refractory Lyme Arthritis, but Not in Rheumatoid Arthritis
  • Abstract Number: 293
    Measurement of Advanced Glycation Endproducts in the Skin of Patients with Idiopathic Inflammatory Myopathies
  • Abstract Number: 2981
    Measurement of Tissue Damage in Scleroderma Using Digital Mammographic Xrays: A Proof of Concept Study
  • Abstract Number: 649
    Measures of Health-Related Quality of Life in Psoriatic Arthritis: Are They Sensitive to Both Joint and Skin Aspects?
  • Abstract Number: 1204
    Measuring the Effectiveness of Patient Education of Patients Receiving Injectable Biologic Medications
  • Abstract Number: 1269
    Measuring the Rheumatologist Workforce in Canada: Preliminary Results of the Stand up and be Counted Survey
  • Abstract Number: 1413
    Medial Meniscus Extrusion and Spontaneous Osteonecrosis of the Knee
  • Abstract Number: 2426
    Medication Taper and Risk of Relapse in Pediatric Uveitis
  • Abstract Number: 2515
    MEK5/ERK5, a Lynchpin of Human Cardiac Fibroblast Transdifferentiation to a Scarring Phenotype in Autoimmune Congenital Heart Block
  • Abstract Number: 1841
    Meningitis in Systemic Lupus Erythematosus Patients: Epidemiologic Profile of Listeria Monocytogenes Infection. a Single-Center Study
  • Abstract Number: 793
    Mesenchymal Stem Cells Promote the Generation of CD206+ Macrophage and Increase Its Phagocytic Activity in Systemic Lupus Erythematosus
  • Abstract Number: 3180
    Mesenchymal Stromal Cell Treatment in Juvenile Idiopathic Arthritis: A Pilot Study
  • Abstract Number: 507
    Meta-Analysis of the Time Course of the Response to Adalimumab Plus Methotrexate or Methotrexate Monotherapy in Clinical Trials of Patients with Rheumatoid Arthritis
  • Abstract Number: 996
    Metabolic Control of Invariant Natural Killer T Cell Function
  • Abstract Number: 2134
    Metabolic Reprogramming in the Inflamed Joint Inhibits Pro-Inflammatory Mechanisms
  • Abstract Number: 1685
    Metabolic Syndrome in Patients with Psoriatic Arthritis Is Associated to Peripheral Disease Activity
  • Abstract Number: 1584
    Metabolic Syndrome Is Associated with Disease Activity in Patients with Rheumatoid Arthritis: A Prospective Cohort Study
  • Abstract Number: 2550
    Metabolomic Profiling of Joints in Murine Models of Inflammatory Arthritis
  • Abstract Number: 574
    Metabolomic Profiling Predicts Outcome of Rituximab Therapy in Rheumatoid Arthritis
  • Abstract Number: 2865
    Methotrexate and Leflunomide Survival in Patients with Psoriatic Arthritis
  • Abstract Number: 579
    Methotrexate Does Not Influence 1-Year Bone Mineral Density in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
  • Abstract Number: 2618
    Methotrexate Dose May Associated with the Frequency of Lymphoproliferative Disorders in Rheumatoid Arthritis
  • Abstract Number: 2439
    Methotrexate Failure in Pediatric Uveitis
  • Abstract Number: 1041
    Methotrexate Monotherapy and Methotrexate Combination Therapy with Traditional and Biologic Dmards for Rheumatoid Arthritis: A Cochrane Systematic Review and Network Meta-Analysis
  • Abstract Number: 2724
    Methotrexate Treatment Could Modulate the Abnormal CD4+T Lymphocyte Subset Distribution in NaÏve Rheumatoid Arthritis Patients
  • Abstract Number: 473
    Methotrexate, Blood Pressure and Arterial Wave Reflection in Rheumatoid Arthritis
  • Abstract Number: 1247
    Methylation Analysis of HLA-B Locus in Familial Behçet Syndrome
  • Abstract Number: 1950
    Methylation-Dependent Interference of Two Promoters for the Treg-Specific Protein, Garp, Contributes to Altered Treg Function in Rheumatoid Arthritis
  • Abstract Number: 2998
    Microchimerism Is Present in Systemic Sclerosis Lung and Includes CD31-Positive Cells
  • Abstract Number: 3044
    Microparticles (MPs) Derived from Cell Plasma Membranes Are Increased in Behcet’s Syndrome (BS) and a Low Ratio of Tissue Factor Pathway Inhibitor Positive Mps to Tissue Factor Positive Mps (TFPI/TF) Is Associated with Thrombosis
  • Abstract Number: 2398
    Microrna Biomarker Signature in Osteoarthritis
  • Abstract Number: 1026
    Microrna-125a-5p Has Increased Expression in Active Systemic Juvenile Idiopathic Arthritis and Is an Essential Modulator of Regulatory Macrophage Phenotypes in Vitro
  • Abstract Number: 541
    Microrna-125b Expression in PBMCs Is Associated with Disease Activity in Patients with Early Rheumatoid Arthritis
  • Abstract Number: 1133
    Microrna-128 Interference Mitigates the Progression of Keen Osteoarthritis By Regulating Sirtuin-1
  • Abstract Number: 935
    Microrna-146a Provides Feedback Regulation of Monosodium Urate-Induced Gouty Arthritis in Mice By Targeting Tumor Necrosis Factor Receptor Associated Factor 6 and Interleukin-1 Receptor-Associated Kinase 1
  • Abstract Number: 3153
    Microrna-155/PU.1 Axis As an Epigenetic Regulator of B-Cells in Rheumatoid Arthritis
  • Abstract Number: 1945
    microRNA-30a Promotes the Inflammatory Response of Rheumatoid Arthritis By Regulating Th1 Cell Differentiation
  • Abstract Number: 2060
    Microscopic Bowel Inflammation in Spondyloarthritis As a Baseline Predictor of Anti-TNF Response
  • Abstract Number: 3067
    Microscopic Colitis in Patients with Takayasu Arteritis; A Potential Association Between the Two Disease Entities
  • Abstract Number: 23
    Microvesicle-Associated Hsa-Mir-223-3p Is Elevated in Rheumatoid Synovial Fluid Compared with Osteoarthritis Synovial Fluid
  • Abstract Number: 749
    Microvesicles Containing Nucleic Acids and Expressing Immunoglobulins and HMGB1 Are Abundant in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 2965
    Might Troponin be a Marker for Subclinical Scleroderma Heart Involvement (SHI)?
  • Abstract Number: 2314
    Minimal Important Difference in HAQ: A Validation from Health Economic Perspectives in Patient with Rheumatoid Arthritis Using Real-World Data
  • Abstract Number: 303
    Mining RNA-Seq of Peripheral Blood Mononuclear Cells from JDM Alone Compared with JDM Plus Psoriasis for Biomarkers of Disease Activity
  • Abstract Number: 1168
    MiR125a-5p Mediates Angiogenic Mechanisms in Inflammatory Arthritis
  • Abstract Number: 1765
    MiR155 Deficient Mice Show Reduced Disease Severity in Pristane-Induced Lupus
  • Abstract Number: 2786
    miR200b-5p: A Possible Predictor of Lymphoma Development in Sjögren’s Syndrome (SS)?
  • Abstract Number: 2135
    miRNA-223 Delivery to Synovial Fibroblasts Via Monocyte-Derived Extracellular Vesicles Promotes Their Proliferation
  • Abstract Number: 682
    Misalignment Between Physician and Patient Satisfaction with Current Psoriatic Arthritis Treatment
  • Abstract Number: 2298
    Misdiagnosis of Fibromyalgia (FM) As Axial Spondylarthritis (SpA): Lessons from Analysis of 26 Cases
  • Abstract Number: 1666
    Mitochondrial Haplogroups in Patients with Rheumatoid Arthritis with Respect to Biological Treatment
  • Abstract Number: 2072
    Mitochondrial Reactive Oxygen Species Modulate Autoimmunity in Systemic Lupus Erythematosus
  • Abstract Number: 2073
    Mitochondrial ROS Is a Novel Regulator of Sting-Mediated Type I IFN Production By Governing Extrusion of Oxidized Mitochondrial DNA upon Neutrophil Extracellular Trap Formation.
  • Abstract Number: 278
    Mitral Valve Prolapse in Patients with Joint Hypermobility Syndrome
  • Abstract Number: 2319
    Mobile Medical Documentation of Patient-Reported-Outcome
  • Abstract Number: 205
    Mode of Action of Therapeutic Anti-Citrullinated Protein Antibodies Revealed: Inflammation Reduction Due to Inhibition of Netosis
  • Abstract Number: 845
    Modelling of Longitudinal Changes in Lung Function in Patients with Systemic Sclerosis and Their Association with Development of Pulmonary Hypertension
  • Abstract Number: 2914
    Modifiable and Non-Modifiable Correlates of Satisfaction with Care in Systemic Lupus Erythematosus
  • Abstract Number: 2025
    Modification of Structural Lesions on Magnetic Resonance Imaging By Etanercept: A 12-Week Randomized Placebo-Controlled Trial
  • Abstract Number: 2846
    Modifications to Biologic Therapy and Economic Implications in Psoriatic Arthritis Patients
  • Abstract Number: 1080
    Modified Rodnan Skin Score Thresholds for the Optimization of Cohort Enrichment in Clinical Trials in Skin Fibrosis in Patients with Diffuse Cutaneous Systemic Sclerosis
  • Abstract Number: 1643
    Modified-Release Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared with Immediate-Release Tofacitinib and Impact of Food
  • Abstract Number: 1751
    Modulation of IRF4 Function Promotes Expansion of Effector Tregs in Lupus
  • Abstract Number: 1261
    Molecular Analysis of Vascular Smooth Muscle Cells from Patients with Giant Cell Arteritis: Targeting Endothelin-1 Receptor to Control Proliferation
  • Abstract Number: 605
    Monitoring of Epstein Barr Virus, Cytomegalovirus and Varicella Zooster Virus Load in Patients Receiving Tocilizumab for Rheumatoid Arthritis
  • Abstract Number: 2132
    Monocarboxylate Transporter 4, Associated with the Acidification of Synovial Fluid, Is a Novel Therapeutic Target for Inflammatory Arthritis
  • Abstract Number: 1911
    Monocyte Chemoattractant Protein-1 (MCP-1, CCL2) Is a Potential Local Marker of Renal Involvement in Scleroderma
  • Abstract Number: 422
    Mood Disorder Is Highly Prevalent in a Multi-Ethnic Urban Pediatric Lupus Cohort
  • Abstract Number: 339
    More Inflammatory Signs on Ultrasound, Severe Pain and Stiffness Are Associated with Erosive Than Non-Erosive Hand Osteoarthritis
  • Abstract Number: 1008
    Morphometric Study of Algerian Hips: An Etiological Study to Explain the Low Prevalence of Hip Osteoarthritis in Algeria
  • Abstract Number: 2946
    Mortality Among SLE Patients in the National Data Bank for Rheumatic Diseases
  • Abstract Number: 2158
    Mortality Associated with Giant Cell Arteritis from 1980 to 2011: An Analysis of the French National Death Certificate Database
  • Abstract Number: 1343
    Mortality Due to Sepsis in Patients with Rheumatoid Arthritis
  • Abstract Number: 60
    Mortality of Systemic Lupus Erythematosus in Puerto Rico Assessed By Multiple-Cause-of-Death Analysis
  • Abstract Number: 2899
    Mortality Related to Pediatric Systemic Lupus Erythematosus: A Multiple Cause-of-Death Analysis in France
  • Abstract Number: 1104
    Mouse B Cells Require Glucose and Free Fatty Acids As Carbon Sources for Cytokine and Chemokine Secretion
  • Abstract Number: 465
    MRI Bone Erosion at Baseline Predicts the Subsequent Radiographic Progression in Early-Stage RA Patients Who Achieved in Sustained Clinical Good Response: Sub-Analysis from Nagasaki University Early Arthritis Cohort
  • Abstract Number: 514
    MRI Bone Oedema at Enrollment Predicts the Development of Rapid Radiographic Progression at 1 Year Toward Patients with Early-Stage Rheumatoid Arthritis: Results from Nagasaki University Early Arthritis Cohort       
  • Abstract Number: 2030
    MRI Changes Associated with Neurological Compromise in Acute Pyogenic Vertebral Osteomyelitis: A Retrospective Study of 121 Patients
  • Abstract Number: 1306
    MRI Erosions in Undifferentiated Arthritis. Different Associations with the Collagen IIA N-Terminal Propeptide (PIIANP) and Galectin-3 in Pre-RA and Other Arthritides
  • Abstract Number: 1308
    MRI Measures of Disease Activity and Joint Damage Are Associated with Patient-Reported Outcomes in Rheumatoid Arthritis
  • Abstract Number: 1727
    MRI Vertebral Corner Inflammation Followed By Fat Deposition Is the Strongest Contributor to the Development of New Bone at the Same Vertebral Corner: A Multi-Level Longitudinal Analysis in Patients with Ankylosing Spondylitis
  • Abstract Number: 931
    mTOR Complex 1 Signaling Is Required for the Steady-State in Vivo Development of Inflammatory Monocytes
  • Abstract Number: 687
    Mucosal Dysregulation in First-Degree Relatives of Ankylosing Spondylitis Patients
  • Abstract Number: 1374
    Mucosal-Associated Invariant T- Cells Are Decreased and Functionally Immature in Peripheral Blood of Patients with Primary Sjögren Syndrome
  • Abstract Number: 2594
    Multi-Biomarker Disease Activity Score As a Predictor of Flare in Patients with Rheumatoid Arthritis Who Stop TNF-Alpha-Inhibitor Therapy
  • Abstract Number: 746
    Multi-Center Delphi Exercise Reveals Important Key Items in Classifying SLE
  • Abstract Number: 2820
    Multi-Omics Studies of Gut Microbiota in Enthesitis-Related Arthritis Identify Diminished Microbial Diversity and Altered Typtophan Metabolism As Potential Factors in Disease Pathogenesis
  • Abstract Number: 1350
    Multi-Targeted Loop-Mediated Isothermal Amplification for Rapid Diagnosis of Osteoarticular Tuberculosis in 60 Minutes: Experience from North India
  • Abstract Number: 538
    Multidrug Resistant Lymphocytes of Patients with Rheumatoid Arthritis Are Predictive for DMARD and Glucocorticoid Treatment Response
  • Abstract Number: 2638
    Multiple Psychosocial Factors Influence Subjective Assessments of Disease Activity in Rheumatoid Arthritis
  • Abstract Number: 253
    Multiple Serum Cytokine Profiling to Identify Specific Molecular Networks in Attacks of Familial Mediterranean Fever
  • Abstract Number: 3264
    Multiplex Serum Protein Analysis in Systemic Sclerosis Defines Potential Anti-Fibrotic Mechanisms and Markers of Response to Hyperimmune Caprine Serum
  • Abstract Number: 2699
    Muscle Inflammation Relates to Disease Activity and Disability but Not Insulin Resistance in Rheumatoid Arthritis
  • Abstract Number: 1398
    Musculoskeletal and Serologic Findings in an Adult Cystic Fibrosis Clinic Population-a Systematic Review and Collation with Disease Status
  • Abstract Number: 1465
    Musculoskeletal Anomalies in Children with Trisomy 21
  • Abstract Number: 1833
    Musculoskeletal Complications of Systemic Lupus Erythematosus: Risk Factors for and Prevalence of Avascular Necrosis and Osteoporosis
  • Abstract Number: 2967
    Musculoskeletal Involvement in SSc Correlates with Poor Short Form 36 and SSc Health Assessment Questionnaire Scores As Well As Lower TNF-Alpha Gene Expression in PBMCs
  • Abstract Number: 925
    Musculoskeletal Ultrasound (MSK-US): Innovation or Overutilization?
  • Abstract Number: 1186
    Musculoskeletal Ultrasound Education Among Rheumatology Fellowship Programs in the United States
  • Abstract Number: 2691
    Musculoskeletal Ultrasound in Multi-Center Rheumatoid Arthritis Clinical Trials: Methodology for Optimizing Reliability of Acquisition and Real-Time Scoring
  • Abstract Number: 831
    Mycophenolate Decreases the Frequency of Endoscopic Therapy for Gastric Antral Vascular Ectasia in Patients with Systemic Sclerosis
  • Abstract Number: 2985
    Mycophenolate Mofetil (MMF) Use in Systemic Sclerosis (SSc) Patients with a Designation of Elevated Systolic Pulmonary Artery Pressure (sPAP): Forced Vital Capacity (FVC), Outcomes and Survival from the European Scleroderma Trials and Research (EUSTAR) Database
  • Abstract Number: 2378
    Mycophenolate Mofetil As a Steroid Sparing Agent in Polymyositis and Dermatomyositis:  a Systematic Review of the Literature
  • Abstract Number: 724
    Mycophenolate Mofetil in Non-Renal Manifestations of Systemic Lupus Erythematosus.  an Observational Cohort Study
  • Abstract Number: 1790
    Mycophenolate Mofetil Suppresses Humoral Response to Pneumococcal Vaccine in Patients with Systemic Lupus Erythematosus and Other Autoimmune Diseases
  • Abstract Number: 1886
    Myocardial Fibrosis Detected By Magnetic Resonance Imaging Is a Predictor of Heart Failure in Systemic Sclerosis (SSc) Patients
  • Abstract Number: 1817
    Myocardial Tissue Characterization with Native Myocardial T1 Mapping in SLE Patients with Chest Pain
  • Abstract Number: 288
    Myositis Associated Interstitial Lung Disease: Clinical Predictors of Failure to Conventional Treatment and Their Response to Tacrolimus
  • Abstract Number: 2368
    Myositis Specific-Autoantibodies: Predictors of Short-Term Good Outcome in Rituximab Treated-Refractory Idiopathic Inflammatory Myopathies
Jump to:  View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology